CMC Solutions

Advancing Biologics Development with Integrated CMC Solutions

Your partners for success

Developing biotechnology products requires the need to balance cost, time, and probability of success. As your partner, we’ll provide strategic advice and solutions designed to ensure success across the full product lifecycle.

Helping you navigate the complex demands of product development

Your Alira Health team has in-depth understanding of the technical and regulatory challenges of drug development. Led by Steven Chamow, PhD, an industry leading expert with over 30 years of experience, our team of subject matter experts will work closely with you to guide you through the most demanding projects.

Meet our team
The Alira Health team is essential when it comes to delivering our products on time with the right quality.
Peter Frank
Head of CMC, ITB-MED

Why choose Alira Health?

For over a decade, our dedicated CMC team has provided tailored solutions to our clients from engagement to launch. With many years of industry experience, we provide clients with the following:

  • Comprehensive, integrated CMC services with a flexible service model that grows with your programs
  • Knowledgeable industry experts who deliver scalable, actionable insights
  • A focus on risk management that is designed to ensure completion of your technical goals
  • Commitment to client advocacy with vendors to drive holistic solutions tailored to your business needs and goals

Working together to transform healthcare

Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.

Contact us
Steve Chamow
Senior Vice President, CMC
Integrity, competence, and collaboration are the foundation of our partnerships. This has allowed us—for over a decade—to help clients succeed in bringing new medicines to market.

Related News

Clinical
News June 8, 2021
Alira Health Expands Its Global Clinical and Data Capabilities Through the Acquisition of CROS NT
We have acquired CROS NT, a data-driven Contract Research Organization (CRO) headquartered in Italy with offices across Europe and the United States. CROS NT provides high quality,(...)
Clinical
Publications April 6, 2021
Unlocking the Database Lock Process
In our latest whitepaper, in collaboration with CROS NT, Alira Health’s Vice President Clinical Development, Christopher Rao and Amanda Cross, US Country Manager Executive Director,(...)
Clinical Regulatory
News January 7, 2021
Alira Health Adds CMC Services through Acquisition of Chamow & Associates
We have acquired Chamow & Associates (www.chamowassociates.com), a California-based integrated CMC advisory firm. This acquisition brings expertise in biologics manufacturing, quality(...)
Clinical
Publications September 4, 2020
Clinical Trial Management – The Dharmic Approach
In this article, Sheryl Kelley, Alira Health’s Associate Director of Data Quality and Finance (and certified yoga instructor), writes about the connections between yoga, dharma, and(...)
Clinical
Publications July 1, 2020
Clinical Trials Trends: Remote Monitoring
The COVID-19 pandemic caused an urgent need to transition clinical trials from on-site to remote monitoring. Though the concept of remote monitoring existed before the pandemic, with(...)
Clinical
Publications May 6, 2020
What You Should Know before Selecting a CRO
When running a clinical trial, it is important to choose the right CRO. This choice impacts the quality and experience of conducting the study.
Clinical
Publications May 1, 2020
Four Critical Factors for Clinical Trial Budget Success
Planning a relevant and accurate budget, regardless of the trial phase or indication, can be one of the most challenging aspects of the clinical trial process. Though it is one of(...)

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.